Bringing Innovation to Market with Digital Therapeutics

Fierce Females in the Life Science Space

The latest news for pharma industry insiders.

March 29th 2024

Solving the First Mile Problem: Q&A with Mark Melton

In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.

Gen-Z Influence on Pharma M&A

Melton, customer advocacy executive at Magnolia, discusses how new technologies can be used to ensure data is accurate.

March 14th 2024

Novartis, Medicines for Malaria Venture Release Positive Results from Phase II/III Trial of Coartem for Infants with Malaria

Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.

FDA Approves Utility Therapeutics’ Pivya to Treat Uncomplicated Urinary Tract Infections in Adult Females

Companies reported that the new formulation of Coartem met required pharmacokinetic profiles and displayed promising efficacy and safety treating malaria in infants.

Pharma Pulse 4/26/24: 20 States Select Direct Care Workforce Enhancement Programs by HHS, Do Assigned Roles in Clinical Trials Affect Patient-Reported Outcomes? & more

Pivya has shown efficacy against bacteria strains such as Escherichia coli, Proteus mirabilis, and Staphylococcus saprophyticus.

Related Content

Fierce Females in the Life Science Space

The latest news for pharma industry insiders.

March 29th 2024

Solving the First Mile Problem: Q&A with Mark Melton

Gen-Z Influence on Pharma M&A

Melton, customer advocacy executive at Magnolia, discusses how new technologies can be used to ensure data is accurate.

March 14th 2024

Novartis, Medicines for Malaria Venture Release Positive Results from Phase II/III Trial of Coartem for Infants with Malaria

Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.

FDA Approves Utility Therapeutics’ Pivya to Treat Uncomplicated Urinary Tract Infections in Adult Females

Companies reported that the new formulation of Coartem met required pharmacokinetic profiles and displayed promising efficacy and safety treating malaria in infants.